Reuben Ovadia has a strong expertise in Organic Chemistry and in the design of therapeutic molecules particularly. He joined ICOSA in February 2019 as a Patent Associate in the Biotech-Chemistry team, where he is involved in drafting and prosecuting patent applications.
PhD in Medicinal Chemistry, he conducted his research at the Laboratory of Architecture and Function of Biological Macromolecules (AFMB, UMR 7257) on the design of dinucleotide analogues (PNA – Peptide Nucleic Acids) targeting the NS5B polymerase of the Hepatitis C Virus, including the development of an original method for the synthesis of these molecules, based on a multicomponent reaction.
Then he joined Dr Raymond Schinazi’s group at Emory University (Atlanta, Ga, USA), as a researcher, where he developed his expertise in antiviral chemistry, particularly in the synthesis of nucleosides, nucleotides and peptides as viral polymerase and protease inhibitors as well as in the field of liver diseases (small molecules).
Reuben Ovadia has co-authored several scientific articles in international peer-reviewed journals, and has presented his work at national and international conferences.